Biotheus has entered into a license and collaboration agreement with Hansoh Pharma for its EGFR/MET bispecific antibody in the Greater China territory

ZHUHAI, China, Nov. 14, 2022 /PRNewswire/ -- Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics...

Related Keywords

China ,Taiwan ,United States ,Hong Kong ,Macao ,Macau General ,Macau ,Chinese ,Almonertinib Ameile ,Flumatinib Xinfu ,Tenofovir Amibufenamide ,Inebilizumab Xinyue ,Xiaolin Liu ,Morinidazole Mailingda ,Yun Sun ,Hansoh Pharma ,Hansoh Pharmaceuticals ,Prnewswire Biotheus Inc ,Biotheus Inc ,Greater China ,Mainland China ,Managing Director ,Chief Executive Officer ,